AU
UK
CA
NZ
IND
US
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Even as Bitcoin (CRYPTO: BTC) has hit a new all-time high above $111,000, driven by surging institutional demand, tightening supply, and macroeconomic tailwinds, experts caution the rally …
BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $74 from $68 and keeps a Buy rating on the shares after meeting with its management team. The firm expects Q1 sales strength to continue into Q2 and sees the company’s FY25 outlook …
Key Points Investors may prefer to hunt for strong dividends right now, as opposed to playing in the volatile stock market. While not as many can be found in the tech-heavy Nasdaq Composite Index, there are still several stocks with strong dividends. Good dividend …
BofA raised the firm’s price target on Dycom (DY) to $250 from $210 and keeps a Buy rating on the shares after fiscal Q1 results that beat BofA and the Street estimates in part due to outsized revenues from the company’s Black and Veatch …
Rosenblatt analyst Blair Abernethy raised the firm’s price target on Autodesk (ADSK) to $345 from $340 and keeps a Buy rating on the shares after the company reported Q1 results marginally ahead of the firm’s forecast. For its updated outlook, the positive impact of …
Key Insights The projected fair value for DoorDash is US$348 based on 2 Stage Free Cash Flow to Equity DoorDash's US$206 share price signals that it might be 41% undervalued The US$217 analyst price target for DASH is 38% less than our estimate of …
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems the …
Key Insights Given the large stake in the stock by institutions, Adobe's stock price might be vulnerable to their trading decisions The top 25 shareholders own 46% of the company Insiders have bought recently This technology could replace computers: discover the 20 stocks are …
Photo: Andrew Harnik (Getty Images), Justin Sullivan (Getty Images), Win McNamee (Getty Images), Ethan Swope (Getty Images), Kevin Dietsch (Getty Images), Dan Kitwood (Getty Images), Brandon Bell (Getty Images), Scott Olson/Getty (Getty Images), Chris McGrath/Getty (Getty Images), Justin Sullivan (Getty Images) The bond market …
Key Points Alnylam Pharmaceuticals has had a lot of excitement this year, with more good news potentially on the way. Axsome Therapeutics should have plenty of upside left, thanks in large part to its depression drug Auvelity. Summit Therapeutics could keep its momentum going …
Please wait processing your request...